AEON Biopharma
Why Robinhood?
You can watch AEON Biopharma and buy or sell other stocks, options, and ETFs commission-free!
About AEON
AEON Biopharma is a biopharmaceutical company focused on the development of ABP-450, a proprietary 900 kDabotulinum toxin complex, for debilitating medical conditions. The company is dedicated to developing novel and proprietary treatment paradigms in order to improve patient outcomes and drive increased value for patients, physicians, and payers.
CEO
Marc Forth
Employees
—
Headquarters
Newport Beach, California
Founded
2012
AEON Key Statistics
Market cap
—
Price-Earnings ratio
—
Dividend yield
—
Average volume
—
High today
—
Low today
—
Open price
—
Volume
0.00
52 Week high
—
52 Week low
—